个人科研网厅 | | 帮助
首都医科大学宣武医院知识库
高级检索
当前位置： 首页 > 详情页

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives.

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ ESCI

作者：
Weber Christopher J[1,*1] * ; Carrillo Maria C[1] ; Jagust William[2] ; Jack Clifford R[3] ; Shaw Leslie M[4] ; Trojanowski John Q[5] ; Saykin Andrew J[6] ; Beckett Laurel A[7] ; Sur Cyrille[8] ; Rao Naren P[9] ; Mendez Patricio Chrem[10] ; Black Sandra E[11] ; Li Kuncheng[12] ; Iwatsubo Takeshi[13] ; Chang Chiung-Chih[14] ; Sosa Ana Luisa[15] ; Rowe Christopher C[16] ; Perrin Richard J[17] ; Morris John C[18] ; Healan Amanda M B[19] ; Hall Stephen E[1] ; Weiner Michael W[20] ;
机构： [1]Alzheimer's Association Chicago Illinois USA. [2]School of Public Health and Helen Wills Neuroscience Institute University of California Berkeley Berkeley California USA. [3]Department of Radiology Mayo Clinic Rochester Minnesota USA. [4]Department of Pathology and Laboratory Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA. [5]Department of Pathology and Laboratory Medicine Perelman School of Medicine Institute on Aging Perelman School of Medicine Alzheimer's Disease Core Center, Perelman School of Medicine Udall Parkinson's Research Center Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA. [6]Department of Radiology and Imaging Sciences and the Indiana Alzheimer's Disease Research Center Department of Medical and Molecular Genetics Indiana University School of Medicine Indianapolis Indiana USA. [7]Division of Biostatistics Department of Public Health Sciences University of California Davis California USA. [8]Merck Research Laboratories Merck Kenilworth New Jersey USA. [9]Department of Psychiatry National Institute of Mental Health and Neurosciences Bengaluru Karnataka India. [10]Centro de Memoria FLENI Montañeses, 2325 (C1428AQK), Bs As Buenos Aires Argentina. [11]Department of Medicine (Neurology) Hurvitz Brain Sciences Program Canadian Partnership for Stroke Recovery, and LC Campbell Cognitive Neurology Research Unit Hurvitz Brain Sciences Research Program Sunnybrook Research Institute Sunnybrook Health Sciences Centre University of Toronto Toronto Canada. [12]Department of Radiology Xuanwu Hospital of Capital Medical University Beijing China. [13]Department of Neuropathology Graduate School of Medicine The University of Tokyo Tokyo Japan. [14]Department of General Neurology and Institute for Translational Research in Biomedicine Kaohsiung Chang Gung Memorial Hospital Chang Gung University College of Medicine Kaohsiung Taiwan. [15]National Institute of Neurology and Neurosurgery of Mexico Mexico City Mexico. [16]Department of Molecular Imaging and Therapy Austin Health and Florey Department of Neuroscience and Mental Health University of Melbourne Melbourne Victoria Australia. [17]Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Pathology and Immunology Department of Neurology Washington University School of Medicine Saint Louis Missouri USA. [18]Charles F. and Joanne Knight Alzheimer Disease Research Center Department of Neurology Washington University School of Medicine Saint Louis Missouri USA. [19]Independent Science Writer and Editor Nashville Tennessee USA. [20]Department of Veterans Affairs Medical Center Center for Imaging of Neurodegenerative Diseases Department of Radiology Department of Medicine Department of Psychiatry Department of Neurology University of California San Francisco California USA.
出处：
DOI： 10.1002/trc2.12226

关键词： Alzheimer’s disease amyloid biomarkers cerebrospinal fluid cognitive impairment MRI neuroimaging PET Tau

摘要：
The Worldwide Alzheimer's Disease Neuroimaging Initiative (WW-ADNI) is a collaborative effort to investigate imaging and biofluid markers that can inform Alzheimer's disease treatment trials. It is a public-private partnership that spans North America, Argentina, Australia, Canada, China, Japan, Korea, Mexico, and Taiwan. In 2004, ADNI researchers began a naturalistic, longitudinal study that continues today around the globe. Through several successive phases (ADNI-1, ADNI-GO, ADNI-2, and ADNI-3), the study has fueled amyloid and tau phenotyping and refined neuroimaging methodologies. WW-ADNI researchers have successfully standardized analyses and openly share data without embargo, providing a rich data set for other investigators. On August 26, 2020, the Alzheimer's Association convened WW-ADNI researchers who shared updates from ADNI-3 and their vision for ADNI-4.© 2021 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, LLC on behalf of Alzheimer's Association.

基金：
CCC’s WW-ADNI project is sponsored by Chang Gung Memorial Hospital, CMRPG 8J0522. AJS receives support from multiple NIH grants related to analysis of ADNI data (P30 AG010133, R01 AG019771, R01 AG057739, U01 AG024904, R01 LM013463, R01 AG068193, and U01 AG068057). The National Centralized Repository for Alzheimer’s Disease and Related Dementias (NCRAD) provides support for ADNI Genetics Core Biobanking and is supported by the NIH (U24 AG021886). CCR has received funding from the National Health and Medical Research Council of Australia. SEB has received funding from the Canadian Institutes of Health Research Foundation Grant (#159910, #142381, and #112246) and the LC Campbell Foundation. LMS has Grant support for AD biomarker studies in CSF and plasma: ADNI3 grant, Biomarker Core, U19AG024904; UPenn ADRC P30AG010124; and MJFox Foundation for Parkinson’s Research, grant #005441
语种：
外文
被引次数：
WOS：
PubmedID：
JCR分区：
出版当年[2019]版：
无
最新[2023]版：
Q1 CLINICAL NEUROLOGY Q1 NEUROSCIENCES

影响因子： 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版]

第一作者：
第一作者机构： [1]Alzheimer's Association Chicago Illinois USA. [*1]Global Science Initiatives, Alzheimer’s Association, 225 N. Michigan Ave. 18th floor, Chicago, IL 60601, USA.
通讯作者：
通讯机构： [1]Alzheimer's Association Chicago Illinois USA. [*1]Global Science Initiatives, Alzheimer’s Association, 225 N. Michigan Ave. 18th floor, Chicago, IL 60601, USA.
推荐引用方式(GB/T 7714)：
Weber Christopher J,Carrillo Maria C,Jagust William,et al.The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives.[J].ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS.2021,7(1):doi:10.1002/trc2.12226.
APA：
Weber Christopher J,Carrillo Maria C,Jagust William,Jack Clifford R,Shaw Leslie M...&Weiner Michael W.(2021).The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives..ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS,7,(1)
MLA：
Weber Christopher J,et al."The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI-3 updates and global perspectives.".ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS 7..1(2021)

相关文献

[1]Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment [2]Lipid metabolism and oxidative stress in patients with Alzheimer's disease and amnestic mild cognitive impairment [3]轻度认知障碍患者脑脊液Tau蛋白及β淀粉样蛋白水平检测的意义 [4]轻度认知障碍患者脑脊液Tau蛋白及β淀粉样蛋白水平检测的意义 [5]Age-associated changes of cerebrospinal fluid amyloid-beta and tau in cynomolgus monkeys [6]Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in non-demented adults: The CABLE study [7]Concordance between the assessment of A beta 42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid [8]Elevated serum sodium is linked to increased amyloid-dependent tau pathology, neurodegeneration, and cognitive impairment in Alzheimer's disease [9]Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application. [10]High-Throughput Metabolomics for Discovering Potential Biomarkers and Identifying Metabolic Mechanisms in Aging and Alzheimer’s Disease(Open Access)

资源点击量：16409 今日访问量：0 总访问量：869 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持：重庆聚合科技有限公司 地址：北京市西城区长椿街45号宣武医院